Institutional investors purchased a net $855.9 thousand shares of GENT during the quarter ended March 2013. This may signal that the smart money is gaining interest in this company as the 45.78% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK ADVISORS LLC Bought 696.1 Thousand shares of Gentium SpA